Tag : drug development

Neurology

ECNP 2020

Newsemia
Read clinically focused news coverage of key developments from ECNP 2020. Medscape Psychiatry Source link...
AI/ML

MIT-Takeda program launches

Newsemia
In February, researchers from MIT and Takeda Pharmaceuticals joined together to celebrate the official launch of the MIT-Takeda Program. The MIT-Takeda Program aims to fuel...
Pediatrics

New Treatment Developed by Children's Hospital of Philadelphia Shows Success in High-Risk Solid Tumors

Newsemia
In a breakthrough study, researchers at Children’s Hospital of Philadelphia (CHOP) have shown that an enhanced treatment developed in their lab leads to long-term remissions...
AI/ML

MIT-Takeda program launches

Newsemia
In February, researchers from MIT and Takeda Pharmaceuticals joined together to celebrate the official launch of the MIT-Takeda Program. The MIT-Takeda Program aims to fuel...
Latest News

COVID-19 Daily: First Vaccine Data, Antibody Test Issues

Newsemia
These are the coronavirus stories you need to know about today. Source link...
Latest News

What Do Early Remdesivir Data Suggest?

Newsemia
Just published data on compassionate use of the investigational drug remdesivir in hospitalized patients with severe COVID-19 suggests a benefit, but one expert says the...
Latest News

Huge Global Effort for Clinical Trials in COVID-19

Newsemia
Researchers worldwide are now collaborating in almost 60 gold-standard clinical trials in a huge research effort to find an effective treatment against COVID-19. Source link...
Neurology

Suicidal Patients Often Excluded From Antidepressant Trials

Newsemia
Clinical trials of antidepressants that inform FDA approval decisions often exclude suicidal patients, leaving clinicians uncertain of the efficacy of these drugs in this patient...
Neurology

Are FDA Panel Votes on Psych Drugs Tainted by Speakers' COIs?

Newsemia
Members of the public who receive expenses from pharmaceutical study sponsors to attend FDA advisory panel meetings to testify about new psychiatric drugs are highly...
Neurology

Negative Phase 2 Trial Data Ends Development of PSP Drug

Newsemia
Phase 2 trial results show gosuranemab did not meet primary or key secondary endpoints in patients with progressive supranuclear palsy, leading to discontinuation of the...
Neurology

FDA Okays Cenobamate (Xcopri) for Focal Epilepsy

Newsemia
The FDA has approved cenobamate for seizures in adults with focal epilepsy based on results from two trials of more than 600 patients, as well...
AI/ML

Computer science in service of medicine

Newsemia
MIT’s Ray and Maria Stata Center (Building 32), known for its striking outward appearance, is also designed to foster collaboration among the people inside. Sitting...
AI/ML

Detecting patients’ pain levels via their brain signals

Newsemia
Researchers from MIT and elsewhere have developed a system that measures a patient’s pain level by analyzing brain activity from a portable neuroimaging device. The...
AI/ML

Model predicts cognitive decline due to Alzheimer’s, up to two years out

Newsemia
A new model developed at MIT can help predict if patients at risk for Alzheimer’s disease will experience clinically significant cognitive decline due to the...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World